MedTrace Logo

Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion

NCT06000319 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-11-18

No results posted yet for this study

Summary

The aim of this study is to evaluate the effectiveness and safety of Natural Matrix Protein™ (NMP™) fibers when used in cervical or lumbar interbody fusion in patients with degenerative disc disease (DDD), spinal stenosis, spondylolisthesis undergoing cervical or lumbar interbody spine fusion at no more than 3 adjacent levels.

Conditions

  • Degenerative Disc Disease
  • Degenerative Spondylolisthesis
  • Spinal Stenosis

Interventions

BIOLOGICAL

Natural Matrix Protein (NMP) Fibers

human bone allograft

PROCEDURE

Lumbar interbody fusion

Procedure that involves removing the intervertebral disk from the disk space between between 2 or more vertebrae between L1 and S1. When the disk space has been cleared out, the surgeon fills the void between the vertebrae with a bone void filler.

PROCEDURE

Cervical interbody fusion

Procedure that involves removing the intervertebral disk from the disk space between between 2 or more vertebrae between C2 and T1. When the disk space has been cleared out, the surgeon fills the void between the vertebrae with a bone void filler.

Sponsors & Collaborators

  • Induce Biologics USA Inc.

    lead INDUSTRY

Principal Investigators

  • Mark A Prevost Sr, MD · Alabama Back Institute

  • Mark A Prevost II, MD · Alabama Back Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-04
Primary Completion
2027-02-01
Completion
2027-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06000319 on ClinicalTrials.gov